A detailed history of Public Employees Retirement Association Of Colorado transactions in Exelixis, Inc. stock. As of the latest transaction made, Public Employees Retirement Association Of Colorado holds 32,998 shares of EXEL stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,998
Previous 32,998 -0.0%
Holding current value
$1.19 Million
Previous $741,000 15.52%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$20.34 - $23.73 $79,488 - $92,736
-3,908 Reduced 10.59%
32,998 $741,000
Q1 2024

May 15, 2024

SELL
$20.17 - $23.93 $31,767 - $37,689
-1,575 Reduced 4.09%
36,906 $876,000
Q3 2023

Nov 14, 2023

BUY
$19.04 - $22.74 $317,244 - $378,893
16,662 Added 76.36%
38,481 $841,000
Q3 2023

Nov 14, 2023

SELL
$19.04 - $22.74 $409,893 - $489,546
-21,528 Reduced 49.66%
21,819 $1.49 Million
Q1 2022

May 16, 2022

SELL
$17.03 - $22.67 $42,915 - $57,128
-2,520 Reduced 5.49%
43,347 $983,000
Q1 2020

May 01, 2020

BUY
$14.46 - $21.8 $41,254 - $62,195
2,853 Added 6.63%
45,867 $790,000
Q1 2019

Apr 30, 2019

SELL
$19.6 - $24.76 $209,759 - $264,981
-10,702 Reduced 19.92%
43,014 $1.02 Million
Q4 2018

Feb 08, 2019

SELL
$13.65 - $21.8 $1,678 - $2,681
-123 Reduced 0.23%
53,716 $1.06 Million
Q3 2018

Oct 29, 2018

SELL
$15.87 - $22.4 $872 - $1,232
-55 Reduced 0.1%
53,839 $954,000
Q2 2018

Aug 02, 2018

SELL
$18.56 - $22.45 $3,563 - $4,310
-192 Reduced 0.35%
53,894 $1.16 Million
Q1 2018

May 01, 2018

BUY
$22.15 - $31.89 $3,189 - $4,592
144 Added 0.27%
54,086 $1.2 Million
Q4 2017

Feb 02, 2018

BUY
$24.23 - $30.93 $44,583 - $56,911
1,840 Added 3.53%
53,942 $1.64 Million
Q3 2017

Oct 30, 2017

BUY
$23.35 - $29.24 $1.22 Million - $1.52 Million
52,102
52,102 $1.26 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Public Employees Retirement Association Of Colorado Portfolio

Follow Public Employees Retirement Association Of Colorado and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.